144 related articles for article (PubMed ID: 27245553)
1. The effects of rabeprazole on metformin pharmacokinetics and pharmacodynamics in Chinese healthy volunteers.
Liu G; Wen J; Guo D; Wang Z; Hu X; Tang J; Liu Z; Zhou H; Zhang W
J Pharmacol Sci; 2016 Dec; 132(4):244-248. PubMed ID: 27245553
[TBL] [Abstract][Full Text] [Related]
2. Effects of proton pump inhibitors on metformin pharmacokinetics and pharmacodynamics.
Kim A; Chung I; Yoon SH; Yu KS; Lim KS; Cho JY; Lee H; Jang IJ; Chung JY
Drug Metab Dispos; 2014 Jul; 42(7):1174-9. PubMed ID: 24764147
[TBL] [Abstract][Full Text] [Related]
3. The effect of lansoprazole, an OCT inhibitor, on metformin pharmacokinetics in healthy subjects.
Ding Y; Jia Y; Song Y; Lu C; Li Y; Chen M; Wang M; Wen A
Eur J Clin Pharmacol; 2014 Feb; 70(2):141-6. PubMed ID: 24170325
[TBL] [Abstract][Full Text] [Related]
4. A non-linear pharmacokinetic-pharmacodynamic relationship of metformin in healthy volunteers: An open-label, parallel group, randomized clinical study.
Chung H; Oh J; Yoon SH; Yu KS; Cho JY; Chung JY
PLoS One; 2018; 13(1):e0191258. PubMed ID: 29342199
[TBL] [Abstract][Full Text] [Related]
5. N(1)-methylnicotinamide as an endogenous probe for drug interactions by renal cation transporters: studies on the metformin-trimethoprim interaction.
Müller F; Pontones CA; Renner B; Mieth M; Hoier E; Auge D; Maas R; Zolk O; Fromm MF
Eur J Clin Pharmacol; 2015 Jan; 71(1):85-94. PubMed ID: 25552403
[TBL] [Abstract][Full Text] [Related]
6. The Effect of Nizatidine, a MATE2K Selective Inhibitor, on the Pharmacokinetics and Pharmacodynamics of Metformin in Healthy Volunteers.
Morrissey KM; Stocker SL; Chen EC; Castro RA; Brett CM; Giacomini KM
Clin Pharmacokinet; 2016 Apr; 55(4):495-506. PubMed ID: 26507723
[TBL] [Abstract][Full Text] [Related]
7. Organic cation transporter and multidrug and toxin extrusion 1 co-mediated interaction between metformin and berberine.
Shi R; Xu Z; Xu X; Jin J; Zhao Y; Wang T; Li Y; Ma Y
Eur J Pharm Sci; 2019 Jan; 127():282-290. PubMed ID: 30428337
[TBL] [Abstract][Full Text] [Related]
8. A drug-drug interaction study to evaluate the impact of peficitinib on OCT1- and MATE1-mediated transport of metformin in healthy volunteers.
Shibata M; Toyoshima J; Kaneko Y; Oda K; Nishimura T
Eur J Clin Pharmacol; 2020 Aug; 76(8):1135-1141. PubMed ID: 32472157
[TBL] [Abstract][Full Text] [Related]
9. The Effect of Famotidine, a MATE1-Selective Inhibitor, on the Pharmacokinetics and Pharmacodynamics of Metformin.
Hibma JE; Zur AA; Castro RA; Wittwer MB; Keizer RJ; Yee SW; Goswami S; Stocker SL; Zhang X; Huang Y; Brett CM; Savic RM; Giacomini KM
Clin Pharmacokinet; 2016 Jun; 55(6):711-21. PubMed ID: 26597253
[TBL] [Abstract][Full Text] [Related]
10. The influence of telmisartan on metformin pharmacokinetics and pharmacodynamics.
Wen J; Zeng M; Liu Z; Zhou H; Xu H; Huang M; Zhang W
J Pharmacol Sci; 2019 Jan; 139(1):37-41. PubMed ID: 30538075
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the multidrug and toxin extrusion (MATE) transporter by pyrimethamine increases the plasma concentration of metformin but does not increase antihyperglycaemic activity in humans.
Oh J; Chung H; Park SI; Yi SJ; Jang K; Kim AH; Yoon J; Cho JY; Yoon SH; Jang IJ; Yu KS; Chung JY
Diabetes Obes Metab; 2016 Jan; 18(1):104-8. PubMed ID: 26381793
[TBL] [Abstract][Full Text] [Related]
12. Tucatinib Inhibits Renal Transporters OCT2 and MATE Without Impacting Renal Function in Healthy Subjects.
Topletz-Erickson AR; Lee AJ; Mayor JG; Rustia EL; Abdulrasool LI; Wise AL; Dailey B; DeChenne S; Walker LN; Alley SC; Endres CJ
J Clin Pharmacol; 2021 Apr; 61(4):461-471. PubMed ID: 32989831
[TBL] [Abstract][Full Text] [Related]
13. A Drug-Drug Interaction Study to Evaluate the Impact of Rimegepant on OCT2- and MATE1-Mediated Transport of Metformin in Healthy Participants.
Bhardwaj R; Morris B; Matschke K; Bertz R; Croop R; Liu J
Clin Pharmacol Drug Dev; 2024 May; 13(5):465-473. PubMed ID: 38174905
[TBL] [Abstract][Full Text] [Related]
14. Proton pump inhibitors inhibit metformin uptake by organic cation transporters (OCTs).
Nies AT; Hofmann U; Resch C; Schaeffeler E; Rius M; Schwab M
PLoS One; 2011; 6(7):e22163. PubMed ID: 21779389
[TBL] [Abstract][Full Text] [Related]
15. Verapamil decreases the glucose-lowering effect of metformin in healthy volunteers.
Cho SK; Kim CO; Park ES; Chung JY
Br J Clin Pharmacol; 2014 Dec; 78(6):1426-32. PubMed ID: 25060604
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic-pharmacodynamic modeling for the relationship between glucose-lowering effect and plasma concentration of metformin in volunteers.
Lee SH; Kwon KI
Arch Pharm Res; 2004 Jul; 27(7):806-10. PubMed ID: 15357011
[TBL] [Abstract][Full Text] [Related]
17. Moxifloxacin Is a Potent In Vitro Inhibitor of OCT- and MATE-Mediated Transport of Metformin and Ethambutol.
Te Brake LH; van den Heuvel JJ; Buaben AO; van Crevel R; Bilos A; Russel FG; Aarnoutse RE; Koenderink JB
Antimicrob Agents Chemother; 2016 Dec; 60(12):7105-7114. PubMed ID: 27645247
[TBL] [Abstract][Full Text] [Related]
18. Influences of organic cation transporter polymorphisms on the population pharmacokinetics of metformin in healthy subjects.
Yoon H; Cho HY; Yoo HD; Kim SM; Lee YB
AAPS J; 2013 Apr; 15(2):571-80. PubMed ID: 23417334
[TBL] [Abstract][Full Text] [Related]
19. No Effect of Plazomicin on the Pharmacokinetics of Metformin in Healthy Subjects.
Choi T; Komirenko AS; Riddle V; Kim A; Dhuria SV
Clin Pharmacol Drug Dev; 2019 Aug; 8(6):818-826. PubMed ID: 30605260
[TBL] [Abstract][Full Text] [Related]
20. The MATE1 rs2289669 polymorphism affects the renal clearance of metformin following ranitidine treatment.
Cho SK; Chung JY
Int J Clin Pharmacol Ther; 2016 Apr; 54(4):253-62. PubMed ID: 26784938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
